ArticleJournal of contemporary brachytherapy2021

High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center.

Bengt Johansson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.